COLLIER ALAN BRIAN (CEO) purchased 0.0% of their position (5.70K shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $13.39 — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+2K
Price / share
$0.00
Trade value
$5.60
% of position
Common Stock
Shares
+1K
Price / share
$0.00
Trade value
$2.50
% of position
Common Stock
Shares
+1K
Price / share
$0.00
Trade value
$2.00
% of position
Common Stock
Shares
+100.00
Price / share
$0.00
Trade value
$0.19
% of position
Common Stock
Shares
+1K
Price / share
$0.00
Trade value
$2.20
% of position
Common Stock
Shares
+500.00
Price / share
$0.00
Trade value
$0.75
% of position
Common Stock
Shares
+100.00
Price / share
$0.00
Trade value
$0.15
% of position
Net shares
+5.70K
Net value
$13.39
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/10/2019 | P · Purchase | +2K | $0.00 | $5.60 | 0.0% | 25.41M | 25.41M |
| Common Stock Direct | 12/10/2019 | P · Purchase | +1K | $0.00 | $2.50 | 0.0% | 25.41M | 25.42M |
| Common Stock Direct | 12/11/2019 | P · Purchase | +1K | $0.00 | $2.00 | 0.0% | 25.42M | 25.42M |
| Common Stock Direct | 12/11/2019 | P · Purchase | +100.00 | $0.00 | $0.19 | 0.0% | 25.42M | 25.42M |
| Common Stock Direct | 12/12/2019 | P · Purchase | +1K | $0.00 | $2.20 | 0.0% | 25.42M | 25.42M |
| Common Stock Direct | 12/16/2019 | P · Purchase | +500.00 | $0.00 | $0.75 | 0.0% | 25.42M | 25.42M |
| Common Stock Direct | 12/20/2019 | P · Purchase | +100.00 | $0.00 | $0.15 | 0.0% | 25.42M | 25.42M |
| Total | +5.70K | $13.39 | ||||||